Kev piav txog
Topirastat Nruab Nrab 2-cyanoisonsicanic acid, Cas. 16123-97-2. Cov khoom no tseem yog paub los ntawm lwm lub npe: 2-cyanopyridine-4-pyridinylic acid, 4-pyridinecarboxylic acid, thiab 4-pyridinecarboxylic acid, 2-cyano-. Cov mis molecular ntawm cov compound intermediate no yog c7h4n2o2 thiab txoj kev molecular hnyav yog 148.1189. Nws yog ib qho tseem ceeb ntawm cov synirastat (ib qho tshuaj siv los kho hyperuricemia hauv cov neeg mob gout).
2-cyanoisonSicicoteinic acid ua si lub cev tseem ceeb hauv kev tsim cov topirastat, uas ua haujlwm los ntawm inhibiting xanthine oxidase, ib qho enzyme koom nrog uric acid ntau lawm. Raws li qhov tshwm sim, urric acid ntau theem hauv cov ntshav txo qis, muab cov tsos mob gout cov tsos mob. Qhov kev sib txuas nruab nrab no yog cov khoom xyaw tseem ceeb hauv kev tsim khoom lag luam ntawm topirastat, ua rau nws ib feem ntawm kev lag luam kws tshuaj.
Xaiv Peb
JDK muaj cov chaw ua haujlwm thawj chav ua haujlwm thiab cov khoom tswj tau zoo, uas paub tias cov khoom siv tau ntawm API Intermediates. Cov kws tshaj lij kev paub tseeb R & D ntawm cov khoom. Tawm tsam ob, peb tab tom tshawb rau cmo & cdmo hauv kev ua lag luam hauv tsev thiab thoob ntiaj teb.
